Patent classifications
C12N2795/10211
<i>Pseudomonas aeruginosa </i>bacteriophage pse-AEP-4 and use thereof for inhibiting proliferation of <i>Pseudomonas aeruginosa</i>
The present invention relates to Podoviridae bacteriophage Pse-AEP-4 (accession number: KCTC 13166BP) isolated from nature, the Podoviridae bacteriophage Pse-AEP-4 having the capability to specifically kill Pseudomonas aeruginosa and having a genome represented by SEQ ID NO: 1, and a method for preventing or treating diseases induced by Pseudomonas aeruginosa by using a composition containing the Podoviridae bacteriophage Pse-AEP-4 as an active ingredient.
<i>Bordetella bronchiseptica </i>bacteriophage Bor-BRP-1, and use thereof for inhibition of proliferation of <i>Bordetella bronchiseptica </i>bacteria
The present invention relates to a Podoviridae bacteriophage Bor-BRP-1 (accession no. KCTC 12705BP) isolated from nature, which has an ability to specifically kill Bordetella bronchiseptica bacteria and has a genome represented by SEQ ID NO: 1; and a method for preventing and treating infection with Bordetella bronchiseptica bacteria using a composition comprising the same as an active ingredient.
NOVEL PSEUDOMONAS AERUGINOSA BACTERIOPHAGE PSE-AEP-4 AND USE THEREOF FOR INHIBITING PROLIFERATION OF PSEUDOMONAS AERUGINOSA
The present invention relates to Podoviridae bacteriophage Pse-AEP-4 (accession number: KCTC 13166BP) isolated from nature, the Podoviridae bacteriophage Pse-AEP-4 having the capability to specifically kill Pseudomonas aeruginosa and having a genome represented by SEQ ID NO: 1, and a method for preventing or treating diseases induced by Pseudomonas aeruginosa by using a composition containing the Podoviridae bacteriophage Pse-AEP-4 as an active ingredient.
NOVEL BORDETELLA BRONCHISEPTICA BACTERIOPHAGE BOR-BRP-1, AND USE THEREOF FOR INHIBITION OF PROLIFERATION OF BORDETELLA BRONCHISEPTICA BACTERIA
The present invention relates to a Podoviridae bacteriophage Bor-BRP-1 (accession no. KCTC 12705BP) isolated from nature, which has an ability to specifically kill Bordetella bronchiseptica bacteria and has a genome represented by SEQ ID NO: 1; and a method for preventing and treating infection with Bordetella bronchiseptica bacteria using a composition comprising the same as an active ingredient.